GlassScriptPhysician profile
Alexander Negron
NPI 1386388924
$7,917.18
in general payments reported to CMS, 2019-2025
15 companies · $6,455 in 2025
The $6,455 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $335 · 2024: $1,127 · 2025: $6,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,350 · Food and Beverage: $3,301 · Travel and Lodging: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,350.00 |
| Food and Beverage | $3,300.50 |
| Travel and Lodging | $266.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,838.07 | 2023-2025 | Titan |
| Teleflex LLC | $660.34 | 2024-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $331.97 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $284.61 | 2023-2025 | General - Erectile Dysfunction, Ams 700 |
| Progenics Pharmaceuticals, INC. | $239.90 | 2024 | |
| Endo USA, INC. | $213.73 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $151.06 | 2023-2025 | Xyosted, Tlando |
| Astellas Pharma US INC | $34.29 | 2024 | Myrbetriq |
| Alexion Pharmaceuticals, INC. | $29.99 | 2024 | Ultomiris |
| Endo Pharmaceuticals INC. | $24.07 | 2024 | Xiaflex, Edex, Aveed |
| Abc Home Medical Supply, INC. | $23.82 | 2024 | |
| Hollister Incorporated | $23.82 | 2024 | Vapro Plus Pocket, Infyna Chic, Vapro |
| Halozyme INC | $23.26 | 2023 | |
| Dentsply Ih Ab | $23.18 | 2024 | Lofric |
| Verity Pharmaceuticals INC. | $15.07 | 2025 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Negron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.